DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 210 filers reported holding DIPLOMAT PHARMACY INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $473,000 | -78.7% | 118,523 | -73.9% | 0.00% | -100.0% |
| Q3 2019 | $2,224,000 | -63.7% | 454,084 | -54.8% | 0.00% | -50.0% |
| Q2 2019 | $6,121,000 | +61.1% | 1,005,364 | +53.7% | 0.00% | +100.0% |
| Q1 2019 | $3,799,000 | +173.5% | 654,240 | +533.6% | 0.00% | +100.0% |
| Q4 2018 | $1,389,000 | -95.4% | 103,252 | -93.4% | 0.00% | -88.9% |
| Q3 2018 | $30,174,000 | +31.9% | 1,554,664 | +73.6% | 0.01% | +28.6% |
| Q2 2018 | $22,885,000 | +28.8% | 895,423 | +1.5% | 0.01% | -12.5% |
| Q1 2018 | $17,774,000 | +123.8% | 882,172 | +122.9% | 0.01% | +60.0% |
| Q4 2017 | $7,943,000 | +4.3% | 395,832 | +7.6% | 0.01% | 0.0% |
| Q3 2017 | $7,615,000 | +83.5% | 367,743 | +31.1% | 0.01% | +66.7% |
| Q2 2017 | $4,149,000 | -30.1% | 280,399 | -24.6% | 0.00% | -25.0% |
| Q1 2017 | $5,932,000 | -26.5% | 371,998 | -41.9% | 0.00% | -33.3% |
| Q4 2016 | $8,070,000 | +165.7% | 640,527 | +490.5% | 0.01% | +200.0% |
| Q3 2016 | $3,037,000 | +19.8% | 108,472 | +49.7% | 0.00% | 0.0% |
| Q2 2016 | $2,535,000 | -11.3% | 72,450 | -30.6% | 0.00% | 0.0% |
| Q1 2016 | $2,858,000 | +31.8% | 104,372 | +64.6% | 0.00% | 0.0% |
| Q4 2015 | $2,169,000 | -39.4% | 63,418 | -49.1% | 0.00% | -33.3% |
| Q3 2015 | $3,580,000 | +119.9% | 124,658 | +242.5% | 0.00% | +200.0% |
| Q2 2015 | $1,628,000 | -39.6% | 36,399 | -53.4% | 0.00% | -50.0% |
| Q1 2015 | $2,697,000 | +591.5% | 78,036 | +445.4% | 0.00% | – |
| Q4 2014 | $390,000 | – | 14,307 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENMEDE TRUST CO NA | 420 | $1,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |